CSL BEHRING AUSTRALIA
CSL Behring Australia offers broadest range of quality plasma-derived and recombinant therapies in industry. Their portfolio of innovative medicines includes recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and alpha-1 antitrypsin deficiency.
CSL BEHRING AUSTRALIA
Industry:
Biotechnology Health Care Medical
Founded:
2012-01-01
Address:
Broadmeadows, Victoria, Australia
Country:
Australia
Website Url:
http://www.cslbehring.com.au
Total Employee:
1001+
Status:
Active
Contact:
+61 3 9246 5200
Email Addresses:
[email protected]
Technology used in webpage:
Microsoft Azure DNS
Official Site Inspections
http://www.cslbehring.com.au Semrush global rank: 3.3 M Semrush visits lastest month: 4.94 K
- Host name: csl.com
- IP address: 12.3.33.229
- Location: Atlanta United States
- Latitude: 33.9707
- Longitude: -84.3247
- Metro Code: 524
- Timezone: America/New_York
- Postal: 30338
More informations about "CSL Behring Australia"
CSL Behring - Wikipedia
CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products. The company is a combination of Behringwerke, founded in 1904 in Marburg, Germany by Emil von Behring, and the Commonwealth Serum Laboratories (CSL), established in Australia in 1916 to provide vaccines to the people of Australia, as well as other companies acq…See details»
Global Biotechnology Company | CSL
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver …See details»
We Are CSL | CSL
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver …See details»
Corporate Governance - CSL
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry. CSL Behring: Rare & Serious Diseases Derived from …See details»
Leading the Way on Rare & Serious Diseases - CSL Behring
CSL Behring is a global biotech company leading the way to deliver innovative therapies for rare and serious diseases. ... NORD, along with its more than 260 patient organization members, is …See details»
CSL Behring Australia - Crunchbase Company Profile & Funding
CSL Behring Australia offers broadest range of quality plasma-derived and recombinant therapies in industry. Their portfolio of innovative medicines includes recombinant and plasma-derived …See details»
Our Company - CSL Behring
It began with a promise. More than 100 years ago, CSL was formed to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, …See details»
Global Leadership Group - CSL Behring
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions Learn More. Careers Careers. Graduate Program. Internship Program. Benefits. …See details»
Our Corporate Profile | Global Biotechnology Company | CSL
Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL -including our three businesses, CSL Behring, CSL Seqirus and …See details»
Driven by Our Promise - CSL Behring
Our restructured end-to-end operations organization and strategy are enhancing our ability to meet growing demand and bring more therapies to more patients. CSL Behring’s …See details»
Global Biotechnology Company | CSL
CSL Behring. Leading the Way in Treating Rare and Serious Diseases. CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including …See details»
CSL Behring - Crunchbase Company Profile & Funding
CSL Behring is a global leader in the plasma protein biotherapeutics industry. They research, develop, manufacture and market biotherapies that are used to treat serious and rare …See details»
Global Selector - CSL Behring
We operate as one integrated global R&D organization that assembles coordinated global project teams. ... CSL Behring is a global biotech leader with a broad range of biotherapies for rare …See details»
Research and Development | CSL Behring Australia
At CSL Behring, innovation is in our DNA. Learn about our commitment to the research & development of new biotherapies for rare and serious diseases. ... CSL’s world-class R&D …See details»
Partnering with CSL - CSL Behring
CSL Behring is a fully integrated biopharmaceutical company with global manufacturing and commercial operations for recombinant proteins, vaccines, biologics, and plasma therapeutics …See details»
Partnering with CSL Behring
CSL Behring is a fully integrated biopharmaceutical company with global manufacturing and commercial operations for recombinant proteins, vaccines, biologics, and plasma therapeutics …See details»
Sustainability at CSL - CSL Behring
We support investigator-initiated studies (IIS) that advance medical and scientific knowledge of CSL Behring products and the diseases they are designed to treat. Read About IIS CSL's …See details»
Our Leadership - CSL
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry. CSL Behring: Rare & Serious Diseases Derived from …See details»
LEAD Grants for European Patient Groups - CSL
Jan 23, 2024 When they have the resources they need, patient advocacy groups can accelerate positive change for the rare disease community. CSL Behring’s LEAD Grant Program in …See details»